What You Should Know:
– Karius®, a leader in genomic diagnostics for infectious disease, announced today the closing of a $100 million Series C funding round.
– Co-led by Khosla Ventures and newcomers 5AM Ventures and…
Continue Reading
AI-driven dermatology platform Cureskin has netted $20 million in a Series B funding round led by HealthQuad. The round was also participated by JSW Ventures, Khosla Ventures, and Sharrp Ventures.”These funds will help further…
Continue Reading
What You Should Know:
– Limbic, a London-based provider of clinical mental health AI technology raises $14M led by Khosla Ventures.
– The funding, which also includes participation from Gaingels and Illusian, will fuel Limbic’s expansion…
Continue Reading
Generative AI startup TORTUS has secured $4.2 million from Khosla Ventures to help in its goal of giving every clinician an AI assistant to automate the clinical documentation process.The company’s O.S.L.E.R (Operating System Leverage…
Continue Reading
Vivodyne started as an idea between Co-Founders Andrei Georgescu (left), now Vivodyne’s CEO, and UPenn Professor Dan Huh (right), now Vivodyne’s CSO, while Andrei performed his Ph.D. graduate studies in Huh’s bioengineering research lab….
Continue Reading
Philadelphia-based AI-enabled biotech company Vivodyne announced it closed a $38 million seed funding round led by Khosla Ventures.CS Ventures, Kairos Ventures, Bison Ventures and MBX Capital also participated in the round.
WHAT THEY DO
Vivodyne is…
Millions of seniors in the U.S. spend their later years in poor and declining health brought on by falls, pain and chronic conditions, signifying a growing disconnect between quality of life and overall longevity….
Continue Reading
What You Should Know:
Bold, a Los Angeles-based healthy aging platform raises $17M in Series A funding led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health,…
Continue Reading
Additional Financing Supports the Further Development of its Suite of Advanced Personalized Health Tests and Expansion into Key Nationwide Retailers such as CVS
Viome Life Sciences, a longevity company committed to translating scientific advancements into…
Viome Life Sciences announced it closed a $86.5 million oversubscribed Series C funding round, bringing its total raise to $175 million. Bold Capital and Khosla Ventures participated in the round alongside existing and new investors.
The…
